Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 46.13B | 46.13B | 41.85B | 41.72B | 27.91B | 16.79B |
Gross Profit | 14.21B | 14.66B | 11.17B | 9.17B | 5.36B | 4.40B |
EBITDA | 8.88B | 9.08B | 6.84B | 3.84B | 1.32B | 1.44B |
Net Income | 5.56B | 5.56B | 4.11B | 2.16B | 409.46M | 474.78M |
Balance Sheet | ||||||
Total Assets | 46.56B | 46.56B | 44.49B | 36.78B | 34.54B | 27.91B |
Cash, Cash Equivalents and Short-Term Investments | 7.00B | 7.00B | 2.16B | 6.25B | 2.63B | 1.28B |
Total Debt | 3.13B | 3.13B | 6.05B | 8.42B | 5.87B | 7.29B |
Total Liabilities | 8.85B | 8.85B | 14.06B | 14.00B | 15.89B | 9.99B |
Stockholders Equity | 37.22B | 37.22B | 30.46B | 22.80B | 18.68B | 17.93B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.76B | 3.52B | -291.80M | 3.08B | -755.51M |
Operating Cash Flow | 0.00 | 4.47B | 4.05B | 539.70M | 3.31B | -404.09M |
Investing Cash Flow | 0.00 | -2.35B | -4.05B | -3.97B | -282.26M | -1.14B |
Financing Cash Flow | 0.00 | -2.71B | 71.90M | 3.77B | -1.82B | 1.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | 178.17B | 42.08 | 14.51% | 0.44% | 14.93% | 21.24% | |
65 Neutral | 92.18B | 43.47 | 16.95% | 0.21% | 21.50% | 78.82% | |
63 Neutral | 195.65B | 50.26 | 13.18% | 0.44% | 5.63% | -41.01% | |
63 Neutral | 177.77B | 36.66 | 8.64% | 0.42% | 17.95% | 50.93% | |
62 Neutral | 135.92B | 58.16 | 5.91% | 0.27% | 4.09% | -51.04% | |
62 Neutral | ₹223.59B | 37.12 | ― | 0.13% | 2.17% | 28.95% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Himadri Speciality Chemical Ltd. announced that ICRA Limited has assigned credit ratings to its various credit facilities and instruments. The ratings include [ICRA]AA- (Positive) and [ICRA]A1+ for its working capital and commercial paper facilities, indicating a positive outlook and reaffirming the company’s strong credit position.
Himadri Speciality Chemical Limited has experienced a significant increase in trading volume, prompting the Exchange to seek further information to ensure investor interests are protected. The company has responded to the Exchange’s inquiry, aiming to maintain transparency and provide the market with relevant updates.